Increasing Number of Biopharmaceutical Products Qualified with National Standards

Published: 2004-12-24 06:59:00

Updated: 2004-12-24 06:59:00

A total number of biopharmaceutical products that are qualified under the national standards has now increased to 13 items, according to a recent announcement by the Korea Food and Drug Administration (KFDA).

A new list of biopharmaceutical products that are now meeting the national standard...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK